Human skin replacement - Clinical Cell Culture
Alternative Names: CellSpray; CellSpray XPLatest Information Update: 04 Nov 2017
At a glance
- Originator Clinical Cell Culture
- Class Cell therapies
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Burns
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Burns in South Africa (Topical, Suspension)
- 09 Sep 2003 Preregistration for Burns in Belgium (Topical)
- 09 Sep 2003 Clinical Cell Culture has filed a marketing approval application with the Belgium Ministry of Health for Burns